Search Results - "Medin, J A"

Refine Results
  1. 1

    Lentivirus IL‐10 Gene Therapy Down‐Regulates IL‐17 and Attenuates Mouse Orthotopic Lung Allograft Rejection by Hirayama, S., Sato, M., Loisel‐Meyer, S., Matsuda, Y., Oishi, H., Guan, Z., Saito, T., Yeung, J., Cypel, M., Hwang, D. M., Medin, J. A., Liu, M., Keshavjee, S.

    Published in American journal of transplantation (01-06-2013)
    “…The purpose of the study was to examine the effect of lentivirus‐mediated IL‐10 gene therapy to target lung allograft rejection in a mouse orthotopic left lung…”
    Get full text
    Journal Article
  2. 2

    Sphingolipid pathway enzymes modulate cell fate and immune responses by Molino, Tate, McKillop, WM, Medin, JA

    Published in Immunotherapy (01-11-2017)
    “…Sphingolipids (SLs) are a class of essential, bioactive lipids. The SL family includes over 4000 distinct molecules, characterized by their sphingoid base…”
    Get full text
    Journal Article
  3. 3

    Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem progenitor cells by YOSHIMITSU, M, HIGUCHI, K, RAMSUBIR, S, NONAKA, T, RASAIAH, V. I, SIATSKAS, C, LIANG, S.-B, MURRAY, G. J, BRADY, R. O, MEDIN, J. A

    Published in Gene therapy (01-02-2007)
    “…A deficiency in alpha-galactosidase A (alpha-gal A) activity causes Fabry disease. Virus-based delivery of genes can correct cells and establish a sustained…”
    Get full text
    Journal Article
  4. 4

    Differential immune responses mediated by adenovirus- and lentivirus-transduced DCs in a HER-2 neu overexpressing tumor model by Felizardo, T C, Wang, J C M, McGray, R A J, Evelegh, C, Spaner, D E, Fowler, D H, Bramson, J L, Medin, J A

    Published in Gene therapy (01-10-2011)
    “…Recent investigations have demonstrated that adenoviral and lentiviral vectors encoding HER-2 can be utilized in cancer immunotherapy. However, it is not known…”
    Get full text
    Journal Article
  5. 5

    Transduction and Transplantation of Spermatogonia into the Testis of Ram Lambs through the Extra-testicular Rete by Rodriguez-Sosa, JR, Silvertown, JD, Foster, RA, Medin, JA, Hahnel, A

    Published in Reproduction in domestic animals (01-08-2009)
    “…Spermatogonial transplantation will provide a new way to study spermatogenesis in domestic animals, disseminate male genetics and produce transgenic animals,…”
    Get full text
    Journal Article
  6. 6

    Gene therapy for Fabry disease by Sitaskas, C., Medin, J. A.

    Published in Journal of inherited metabolic disease (01-01-2001)
    “…Fabry disease is an X‐linked metabolic disorder caused by a deficiency ofα‐galactosidase A (α‐Gal A). Lack of this lysosomal hydrolase results in…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Novel application of lentiviral vectors towards treatment of graft-versus-host disease by Scaife, Matthew D, Neschadim, Anton, Fowler, D H, Medin, J A

    Published in Expert opinion on biological therapy (01-06-2009)
    “…Allogeneic transplantation of hematopoietic stem cells and lymphocytes is a curative treatment for malignant and non-malignant disease. However, the primary…”
    Get more information
    Journal Article
  8. 8

    Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells by Symes, J C, Siatskas, C, Fowler, D H, Medin, J A

    Published in Cancer gene therapy (01-05-2009)
    “…Adoptively transferred T cells possess anticancer activities partially mediated by T-cell FasL engagement of Fas tumor targets. However, antigen-induced T-cell…”
    Get full text
    Journal Article
  9. 9

    Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer by Neschadim, A, Wang, J C M, Lavie, A, Medin, J A

    Published in Cancer gene therapy (01-05-2012)
    “…Activity and specificity of chemotherapeutic agents against solid tumors can be augmented via the targeted or localized delivery of ‘suicide’ genes. Selective…”
    Get full text
    Journal Article
  10. 10

    Engineered human Tmpk fused with truncated cell-surface markers: versatile cell-fate control safety cassettes by Scaife, M, Pacienza, N, Au, B C Y, Wang, J C M, Devine, S, Scheid, E, Lee, C-J, Lopez-Perez, O, Neschadim, A, Fowler, D H, Foley, R, Medin, J A

    Published in Gene therapy (01-01-2013)
    “…Cell-fate control gene therapy (CFCGT)-based strategies can augment existing gene therapy and cell transplantation approaches by providing a safety element in…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Circulating alpha-galactosidase A derived from transduced bone marrow cells: relevance for corrective gene transfer for Fabry disease by Takenaka, T, Qin, G, Brady, R O, Medin, J A

    Published in Human gene therapy (10-08-1999)
    “…Fabry disease is caused by a deficiency of the lysosomal enzyme alpha-galactosidase A (alpha-gal A). We previously engineered a retrovirus encoding human…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Efficient, Low-Cost Protein Factories: Expression of Human Adenosine Deaminase in Baculovirus-Infected Insect Larvae by Medin, Jeffrey A., Hunt, Laura, Gathy, Karen, Evans, Robert K., Coleman, Mary Sue

    “…Human adenosine deaminase (EC 3.5.4.4), a key purine salvage enzyme essential for immune competence, has been overproduced in Spodoptera frugiperda cells and…”
    Get full text
    Journal Article
  16. 16

    Retrovirus-mediated correction of the metabolic defect in cultured Farber disease cells by Medin, J A, Takenaka, T, Carpentier, S, Garcia, V, Basile, J P, Segui, B, Andrieu-Abadie, N, Auge, N, Salvayre, R, Levade, T

    Published in Human gene therapy (20-05-1999)
    “…Farber disease is a rare severe lysosomal storage disorder due to a deficient activity of the enzyme acid ceramidase (AC). Patients have granulomas along with…”
    Get more information
    Journal Article
  17. 17

    Selection of Transduced CD34+Progenitors and Enzymatic Correction of Cells from Gaucher Patients, with Bicistronic Vectors by Migita, M, Medin, J A, Pawliuk, R, Jacobson, S, Nagle, J W, Anderson, S, Amiri, M, Humphries, R K, Karlsson, S

    “…The gene transfer efficiency of human hematopoietic stem cells is still inadequate for efficient gene therapy of most disorders. To overcome this problem, a…”
    Get full text
    Journal Article
  18. 18

    Recombinant Thyroid Hormone Receptor and Retinoid X Receptor Stimulate Ligand-Dependent Transcription in vitro by Lee, Insong J., Driggers, Paul H., Medin, Jeffrey A., Nikodem, Vera M., Ozato, Keiko

    “…The thyroid hormone and retinoid X receptors form a heterodimer with each other and mediate thyroid hormone (T3)-dependent transcription. Retinoid X receptor,…”
    Get full text
    Journal Article
  19. 19

    Viral vectors for gene therapy of hematopoietic cells by Medin, Jeffrey A., Karlsson, Stefan

    Published in Immunotechnology (01-03-1997)
    “…Hematopoietic cells, in particular hematopoietic stem cells, are important targets for the development of gene therapy for hematological and other disorders…”
    Get full text
    Book Review Journal Article
  20. 20

    Characterization of the chimeric retinoic acid receptor RARα/VDR by PEMRICK, S. M, ABARZUA, P, KRATZEISEN, C, MARKS, M. S, MEDIN, J. A, OZATO, K, GRIPPO, J. F

    Published in Leukemia (01-04-1998)
    “…The chimeric receptor, RARα/VDR, contains the DNA-binding domain of the retinoic acid receptor (RARα) and the ligand-binding domain of the vitamin D receptor…”
    Get full text
    Journal Article